Organovo
Agent44Agent Readiness: 44/100. Above median. Measured by StartupHub.ai. Median 41.Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine
About
Organovo Holdings is a pioneering 3D bioprinting company that designs and develops functional three-dimensional human tissue for medical research and therapeutic applications. Founded in 2007, Organovo uses its proprietary NovoGen MMX Bioprinter technology to create human tissue models used in pharmaceutical drug discovery, toxicology testing, and regenerative medicine research. The company's NAMKind™ Human-Based Toxicology Services platform has expanded internationally through distributor partnerships.
Key facts
At-a-glance profile data
- Website
- organovo.com
- Headquarters
- San Diego, United States
- Founded
- 2007
- Total funding
- $118M
- Business model
- B2B
Tech stack
Detected on organovo.com, last scanned 9 Sept 2026. Run your own scan
- Frontend
- jQuery
- Analytics
- Google Analytics 4, Google Tag Manager
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Hosting
- Google Cloud
Frequently asked
How much funding has Organovo raised?
Organovo has raised a total of $118M in funding.